CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 43 | -18.9% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 53 | +65.6% | 0.00% | – |
| Q3 2019 | $1,000 | -97.6% | 32 | -98.8% | 0.00% | -100.0% |
| Q2 2019 | $42,000 | +10.5% | 2,663 | -6.1% | 0.01% | +25.0% |
| Q4 2018 | $38,000 | +280.0% | 2,836 | +291.7% | 0.01% | +300.0% |
| Q3 2018 | $10,000 | -75.6% | 724 | -72.8% | 0.00% | -77.8% |
| Q2 2018 | $41,000 | -6.8% | 2,663 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $44,000 | – | 2,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |